Proposals On EU-Wide Joint Clinical Assessments Fall Short, Warn German Industry Groups

Methods being designed to implement EU-wide joint clinical assessments introduced by the Health Technology Assessment (HTA) Regulation will not introduce a harmonized approach to the assessments, according to the German pharmaceutical industry associations, the VFA and BPI.

The groups say they want a “directional correction” and warn in a joint position paper that the “fragmented” approach proposed